Published in Nurs Res on September 11, 2007
Defining racial and ethnic disparities in pain management. Clin Orthop Relat Res (2011) 1.12
Self-efficacy for coping with cancer in a multiethnic sample of breast cancer patients: associations with barriers to pain management and distress. Clin J Pain (2010) 1.05
The pain experience of Hispanic patients with cancer in the United States. Oncol Nurs Forum (2007) 1.03
A national online forum on ethnic differences in cancer pain experience. Nurs Res (2009) 0.97
Disparities in the provision of medical care: an outcome in search of an explanation. J Behav Med (2009) 0.94
Pain outcomes of inpatient pain and palliative care consultations: differences by race and diagnosis. J Palliat Med (2011) 0.87
Predictors of cancer-related pain improvement over time. Psychosom Med (2012) 0.87
Hospice referrals and code status: outcomes of inpatient palliative care consultations among Asian Americans and Pacific Islanders with cancer. J Pain Symptom Manage (2011) 0.86
African American cancer patients' pain experience. Cancer Nurs (2008) 0.83
Characteristics of cancer patients in internet cancer support groups. Comput Inform Nurs (2007) 0.81
Apoyo con Cariño: a pilot randomized controlled trial of a patient navigator intervention to improve palliative care outcomes for Latinos with serious illness. J Pain Symptom Manage (2014) 0.79
Acculturation and the cancer pain experience. J Transcult Nurs (2009) 0.78
Consistency and Accuracy of Multiple Pain Scales Measured in Cancer Patients From Multiple Ethnic Groups. Cancer Nurs (2015) 0.77
Practical guidelines for qualitative research using online forums. Comput Inform Nurs (2012) 0.77
Sexual activity and body image: examining gender variability and the influence of psychological distress in cancer patients. J Gend Stud (2013) 0.76
Differences in Clinical Pain and Experimental Pain Sensitivity Between Asian Americans and Whites With Knee Osteoarthritis. Clin J Pain (2017) 0.75
Unresolved Pain Interference among Colorectal Cancer Survivors: Implications for Patient Care and Outcomes. Pain Med (2015) 0.75
Predictors of Quality of Life in Cancer Survivors: White and Asian American Women. Women Ther (2015) 0.75
Issues in Developing and Evaluating a Culturally Tailored Internet Cancer Support Group. Comput Inform Nurs (2016) 0.75
Predictors and use of nonpharmacologic interventions for procedural pain associated with turning among hospitalized adults. Pain Manag Nurs (2010) 0.75
Non-pharmacological cancer pain interventions in populations with social disparities: a systematic review and meta-analysis. Support Care Cancer (2015) 0.75
The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol (1993) 18.75
The short-form McGill Pain Questionnaire. Pain (1987) 14.40
Pain and its treatment in outpatients with metastatic cancer. N Engl J Med (1994) 9.54
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer (1994) 5.63
Pain in children: comparison of assessment scales. Pediatr Nurs (1988) 5.10
Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med (1997) 3.48
Advancing the science of symptom management. J Adv Nurs (2001) 3.14
Minority cancer patients and their providers: pain management attitudes and practice. Cancer (2000) 2.13
Rigor in feminist research. ANS Adv Nurs Sci (1991) 1.95
The memorial symptom assessment scale short form (MSAS-SF). Cancer (2000) 1.94
Racial/ethnic group differences in treatment decision-making and treatment received among older breast carcinoma patients. Cancer (2006) 1.79
Post-treatment symptoms among ethnic minority breast cancer survivors. Oncol Nurs Forum (2005) 1.67
Gender differences in pain, fatigue, and depression in patients with cancer. J Natl Cancer Inst Monogr (2004) 1.21
Measuring quality of life of Chinese cancer patients: A validation of the Chinese version of the Functional Assessment of Cancer Therapy-General (FACT-G) scale. Cancer (2000) 1.17
Validation of the Brief Pain Inventory in a Taiwanese population. J Pain Symptom Manage (1999) 1.12
Evaluation of the Faces Pain Scale for use with the elderly. Clin J Pain (1998) 1.10
Measurement and prevalence of pain in cancer. Semin Oncol Nurs (1985) 1.01
The impact of socio-cultural and clinical factors on health-related quality of life reports among Hispanic and African-American cancer patients. J Outcome Meas (1999) 0.99
No evidence for sex differences in the severity and treatment of cancer pain. J Pain Symptom Manage (2004) 0.98
Ethnic differences in pain among outpatients with terminal and end-stage chronic illness. Pain Med (2005) 0.96
Pain, mood disturbance, and quality of life in patients with multiple myeloma. Oncol Nurs Forum (2001) 0.94
Multimeasure pain assessment in an ethnically diverse group of patients with cancer. J Transcult Nurs (1999) 0.93
The impact of demographic and disease-specific variables on pain in cancer patients. J Pain Symptom Manage (2003) 0.91
White cancer patients' perception of gender and ethnic differences in pain experience. Cancer Nurs (2006) 0.90
Patients' verbal descriptions of pain and discomfort following orthopaedic surgery. Int J Nurs Stud (2002) 0.88
Development of three African language translations of the FACT-G. Qual Life Res (2000) 0.87
A comparison of the Hopkins Pain Rating Instrument with standard visual analogue and verbal descriptor scales in patients with cancer pain. J Pain Symptom Manage (1992) 0.83
The lens model: assessment of cancer pain in a Chinese context. Cancer Nurs (2000) 0.82
Concerns and misconceptions about pain among Hong Kong Chinese patients with cancer. Cancer Nurs (1999) 0.80
KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science (2003) 6.60
The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature (2012) 5.61
The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway. Dev Cell (2008) 5.58
mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science (2010) 4.81
Attenuated cold sensitivity in TRPM8 null mice. Neuron (2007) 4.73
Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science (2005) 4.58
Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature (2007) 4.54
Mesenchymal stem cell-mediated functional tooth regeneration in swine. PLoS One (2006) 3.91
White Collar-1, a circadian blue light photoreceptor, binding to the frequency promoter. Science (2002) 3.85
Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK. Proc Natl Acad Sci U S A (2006) 3.83
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 3.83
Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors. Nature (2010) 3.39
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor. Nat Med (2010) 3.26
R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6. Proc Natl Acad Sci U S A (2007) 3.24
The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. Nat Chem Biol (2010) 3.15
White collar-1, a DNA binding transcription factor and a light sensor. Science (2002) 2.97
Allosteric inhibitors of Bcr-abl-dependent cell proliferation. Nat Chem Biol (2006) 2.96
Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study. J Endod (2008) 2.95
Practical reconstruction method for bioluminescence tomography. Opt Express (2005) 2.83
Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet (2004) 2.66
Cryptochrome mediates circadian regulation of cAMP signaling and hepatic gluconeogenesis. Nat Med (2010) 2.65
A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci U S A (2007) 2.60
A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun (2005) 2.55
CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett (2007) 2.43
Pure spinal epidural cavernous hemangioma. Acta Neurochir (Wien) (2012) 2.38
Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis. J Immunol (2009) 2.37
Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog (2009) 2.36
A general strategy for creating "inactive-conformation" abl inhibitors. Chem Biol (2006) 2.27
Diverse pathways generate microRNA-like RNAs and Dicer-independent small interfering RNAs in fungi. Mol Cell (2010) 2.23
Non-optimal codon usage affects expression, structure and function of clock protein FRQ. Nature (2013) 2.15
Cooperative interactions between CBP and TORC2 confer selectivity to CREB target gene expression. EMBO J (2007) 2.07
Regulation of the Neurospora circadian clock by an RNA helicase. Genes Dev (2004) 2.07
qiRNA is a new type of small interfering RNA induced by DNA damage. Nature (2009) 2.06
Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models. PLoS One (2012) 2.01
Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy. J Gastroenterol (2015) 2.01
Biocompatible copper(I) catalysts for in vivo imaging of glycans. J Am Chem Soc (2010) 1.98
Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci (2002) 1.96
The hidden treasure in apical papilla: the potential role in pulp/dentin regeneration and bioroot engineering. J Endod (2008) 1.95
FWD1-mediated degradation of FREQUENCY in Neurospora establishes a conserved mechanism for circadian clock regulation. EMBO J (2003) 1.89
Molecular mechanism of light responses in Neurospora: from light-induced transcription to photoadaptation. Genes Dev (2005) 1.89
QIP, a putative exonuclease, interacts with the Neurospora Argonaute protein and facilitates conversion of duplex siRNA into single strands. Genes Dev (2007) 1.88
DIVEIN: a web server to analyze phylogenies, sequence divergence, diversity, and informative sites. Biotechniques (2010) 1.88
The Neurospora crassa circadian clock. Adv Genet (2007) 1.86
CKI and CKII mediate the FREQUENCY-dependent phosphorylation of the WHITE COLLAR complex to close the Neurospora circadian negative feedback loop. Genes Dev (2006) 1.85
The COP9 signalosome regulates the Neurospora circadian clock by controlling the stability of the SCFFWD-1 complex. Genes Dev (2005) 1.83
PAS domain-mediated WC-1/WC-2 interaction is essential for maintaining the steady-state level of WC-1 and the function of both proteins in circadian clock and light responses of Neurospora. Mol Cell Biol (2002) 1.82
A radiopathological classification of dural tail sign of meningiomas. J Neurosurg (2012) 1.69
The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies. PLoS Pathog (2013) 1.67
Increasing the efficacy of bioorthogonal click reactions for bioconjugation: a comparative study. Angew Chem Int Ed Engl (2011) 1.66
Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy. Clin Cancer Res (2012) 1.65
R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice. Gastroenterology (2007) 1.64
Convergent antibody signatures in human dengue. Cell Host Microbe (2013) 1.64
eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies. Cancer Res (2012) 1.62
Non-optimal codon usage is a mechanism to achieve circadian clock conditionality. Nature (2013) 1.61
Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proc Natl Acad Sci U S A (2010) 1.60
WHITE COLLAR-1, a multifunctional neurospora protein involved in the circadian feedback loops, light sensing, and transcription repression of wc-2. J Biol Chem (2002) 1.59
Identification of a Kir3.4 mutation in congenital long QT syndrome. Am J Hum Genet (2010) 1.57
Change in knee cartilage T2 at MR imaging after running: a feasibility study. Radiology (2004) 1.56
Regulation of the Neurospora circadian clock by casein kinase II. Genes Dev (2002) 1.56
Circulatory responses to fiberoptic intubation in anesthetized children: a comparison of oral and nasal routes. Anesth Analg (2007) 1.54
Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation (2013) 1.53
Mobilization of mesenchymal stem cells by granulocyte colony-stimulating factor in rats with acute myocardial infarction. Cardiovasc Drugs Ther (2008) 1.53
Effects of aging, cytomegalovirus infection, and EBV infection on human B cell repertoires. J Immunol (2013) 1.51
MicroRNA-107 inhibits U87 glioma stem cells growth and invasion. Cell Mol Neurobiol (2013) 1.51
Downregulation of adiponectin induced by tumor necrosis factor α is involved in the aggravation of posttraumatic myocardial ischemia/reperfusion injury. Crit Care Med (2011) 1.50
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons. J Neurosci (2008) 1.49
A reversible molecular valve. Proc Natl Acad Sci U S A (2005) 1.49
Distinct roles for PP1 and PP2A in the Neurospora circadian clock. Genes Dev (2004) 1.48
PI3K-δ and PI3K-γ inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models. Chem Biol (2013) 1.47
A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model. Chem Biol (2006) 1.47
Dose finding - a challenge in statistics. Biom J (2008) 1.44
Paucity of clinical disease despite serological autoimmunity and kidney pathology in lupus-prone New Zealand mixed 2328 mice deficient in BAFF. J Immunol (2006) 1.43
Protein kinase A and casein kinases mediate sequential phosphorylation events in the circadian negative feedback loop. Genes Dev (2007) 1.43
Immunomodulatory properties of stem cells from human exfoliated deciduous teeth. Stem Cell Res Ther (2010) 1.43
Insulin alleviates posttrauma cardiac dysfunction by inhibiting tumor necrosis factor-α-mediated reactive oxygen species production. Crit Care Med (2013) 1.42
Controlled scalable synthesis of uniform, high-quality monolayer and few-layer MoS2 films. Sci Rep (2013) 1.41
Demographic processes affect HIV-1 evolution in primary infection before the onset of selective processes. J Virol (2011) 1.41
Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway. J Immunol (2009) 1.40
Allogeneic periodontal ligament stem cell therapy for periodontitis in swine. Stem Cells (2010) 1.40
Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice. Eur J Pharm Sci (2011) 1.39
Phosphorylation of FREQUENCY protein by casein kinase II is necessary for the function of the Neurospora circadian clock. Mol Cell Biol (2003) 1.39
Cluster analysis of midlife women's sleep-related symptoms: racial/ethnic differences. Menopause (2015) 1.39
Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype. J Virol (2010) 1.39
High-resolution antibody dynamics of vaccine-induced immune responses. Proc Natl Acad Sci U S A (2014) 1.39
Light-independent phosphorylation of WHITE COLLAR-1 regulates its function in the Neurospora circadian negative feedback loop. J Biol Chem (2005) 1.38
Activation properties of heterologously expressed mammalian TRPV2: evidence for species dependence. J Biol Chem (2007) 1.38
Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet (2006) 1.38
Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ Res (2004) 1.37
Functional conservation of light, oxygen, or voltage domains in light sensing. Proc Natl Acad Sci U S A (2003) 1.37
RNA interference pathways in fungi: mechanisms and functions. Annu Rev Microbiol (2012) 1.35
Ultrasonic flowmeters: half-century progress report, 1955-2005. Ultrasonics (2006) 1.34
Recruitment of research participants through the Internet. Comput Inform Nurs (2004) 1.33
The exosome regulates circadian gene expression in a posttranscriptional negative feedback loop. Cell (2009) 1.33
Anomalous vertebral artery in craniovertebral junction with occipitalization of the atlas. Spine (Phila Pa 1976) (2009) 1.32
Characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates in China. J Clin Microbiol (2008) 1.30
A double-stranded-RNA response program important for RNA interference efficiency. Mol Cell Biol (2007) 1.29
Setting the pace of the Neurospora circadian clock by multiple independent FRQ phosphorylation events. Proc Natl Acad Sci U S A (2009) 1.29
Age dependency of cartilage magnetic resonance imaging T2 relaxation times in asymptomatic women. Arthritis Rheum (2004) 1.28
Sterol-responsive element-binding protein (SREBP) 2 down-regulates ATP-binding cassette transporter A1 in vascular endothelial cells: a novel role of SREBP in regulating cholesterol metabolism. J Biol Chem (2004) 1.27